Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nils Brion"'
Autor:
Marcello Marchetti, Nils Brion, Virginie Gualano, Maria Teresa Rosignoli, Laurette Millerioux, Rossella Picollo, Paolo Dionisio
Publikováno v:
Arzneimittelforschung. 53:201-205
The pharmacokinetic properties and tolerability of three different strengths of prulifloxacin (CAS 123447-62-1), a new antibacterial agent prodrug of AF3013 (CAS 112984-60-8), have been investigated in a randomized, cross-over study performed in 12 C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b05281fb7fcc3a6b4091731c749a2144
https://doi.org/10.1055/s-0031-1297095
https://doi.org/10.1055/s-0031-1297095
Autor:
Eric Pujade-Lauraine, Nils Brion, Bernard Paule, Jean Pierre Droz, Jacques Bons, Susy Scholl, Azab M, Pierre Pouillart, Michel Marty, Dominic Paes
Publikováno v:
New England Journal of Medicine. 322:816-821
To compare ondansetron (GR 38032F), a 5-hydroxytryptamine3-receptor antagonist, with metoclopramide in the prophylaxis of acute cisplatin-induced emesis, we conducted a double-blind crossover study in 97 patients scheduled to receive cisplatin (80 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17eada07f72d21b2aadda1089689fad1
https://doi.org/10.1056/nejm199003223221205
https://doi.org/10.1056/nejm199003223221205
Publikováno v:
Cancer chemotherapy and pharmacology. 23(6)
A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/m2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115cc409d50ce0dd7d637d54e0c7b30f
https://pubmed.ncbi.nlm.nih.gov/2523762
https://pubmed.ncbi.nlm.nih.gov/2523762
Publikováno v:
The Lancet. 322:1419
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::310acb1f58c7e44a8809440082c4ee8b
https://doi.org/10.1016/s0140-6736(83)90945-5
https://doi.org/10.1016/s0140-6736(83)90945-5